Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients

BACKGROUND: Recurrence of cancer after curative surgery is a major problem after most cancer treatments. Increased sympathetic activity during the perioperative period could promote cancer cell invasion to blood vessels and angiogenesis, resulting in cancer metastasis. Recent studies showed that use...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Trials
Main Authors: Yamamoto, Haruko, Hamasaki, Toshimitsu, Onda, Kaori, Nojiri, Takashi, Aragaki, Masato, Horie, Nao, Sato, Norihiro, Hida, Yasuhiro
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6907139/
https://ncbi.nlm.nih.gov/pubmed/31829248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3904-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares